Article
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
Atherosclerosis - 1 Dec 2011
Brautbar Ariel, Covarrubias Daniel, Belmont John, Lara-Garduno Fremiet, Virani Salim S, Jones Peter H, Leal Suzanne M, Ballantyne Christie M
Abstract excerpt
OBJECTIVE: Atherogenic dyslipidemia is highly associated with coronary heart disease and is characterized by elevated triglycerides (TG), low high-density lipoprotein cholesterol (HDL-C), and elevated low-density lipoprotein cholesterol (LDL-C). The combination of statins and fibrates is a common modality to treat individuals with atherogenic dyslipidemia. We sought to identify single nucleotide polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.